Grantee Spotlight: SAKK 01/18 Trial Drives Change in Global Cancer Guidelines
Grantee Spotlight: SAKK 01/18 Trial Drives Change in Global Cancer Guidelines August 7, 2025 We’re proud to share a major milestone achieved by one of our completed grants: the “SAKK 01/18 trial: Reduced intensity radio-chemotherapy for stage IIA/B seminoma” has led to a significant update in the National Comprehensive Cancer Network (NCCN) guidelines (image 1). Led by Dr. …
Grantee Spotlight: SAKK 01/18 Trial Drives Change in Global Cancer Guidelines Read More »








